Analysts at Deutsche Bank downgrade Medco Health Solutions Inc (NYSE:
MHS) from “buy” to “hold.” The target price for MHS has been lowered from $77 to $55.
MHS shares fell 2.72% to close at $53.19 on Friday.
More Analyst Ratings here© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
